Australia markets open in 4 hours 36 minutes

ALK-Abelló A/S (0OIR.IL)

IOB - IOB Delayed price. Currency in DKK
Add to watchlist
149.450.00 (0.00%)
At close: 05:35PM BST

ALK-Abelló A/S

Boge Alle 6-8
Horsholm 2970
Denmark
45 45 74 75 76
https://www.alk.net

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees2,727

Key executives

NameTitlePayExercisedYear born
Mr. Carsten HellmannPres, CEO & Member of Management Board14.37MN/A1964
Mr. Søren Daniel NiegelExec. VP of Commercial Operations & Member of Management Board5.8MN/A1971
Ms. Katja Barnkob ThalundProject Director of Global CMC Devel. & Employee-elected Director350kN/A1969
Mr. Claus Steensen SoljeExec. VP, CFO & Member of Management BoardN/AN/A1962
Dr. Henriette MersebachExec. VP R&D & Member of Management BoardN/AN/AN/A
Mr. Per PlotnikofVP of Corp. Communications, Investor Relations & Strategic Planning and Head of IRN/AN/AN/A
Prof. Hendrik Kees Kam Nolte M.D., Ph.D.Sr. VP of Research & Devel. - North America and International MarketsN/AN/AN/A
Mr. Christian G. HoughtonHead of Product SupplyN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in DKK.

Description

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. It product portfolio include GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food. It also provides consumer healthcare solution, which include Digital eco-system, a platform which connect and engages with allergy sufferers much earlier in the disease journey through tools and e-commerce offerings that supports, guidance and relief, and smoothing the path to allergy immunotherapy treatment. In addition, the company offers diagnostic allergy solutions through testing by skin prick test or blood test; and emergency treatment, such as intramuscular injection of adrenaline for the treatment of acute life-threatening allergic reactions including Anaphylaxis. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.

Corporate governance

ALK-Abelló A/S’s ISS governance QualityScore as of 1 October 2023 is 6. The pillar scores are Audit: 1; Board: 3; Shareholder rights: 10; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.